Lintopride structure
|
Common Name | Lintopride | ||
---|---|---|---|---|
CAS Number | 107429-63-0 | Molecular Weight | 310.77900 | |
Density | 1.35g/cm3 | Boiling Point | 494.1ºC at 760 mmHg | |
Molecular Formula | C14H19ClN4O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 252.6ºC |
Use of LintoprideLintopride is a 5HT4 antagonist with moderate 5HT3 antagonist properties. |
Name | 4-amino-5-chloro-N-[(1-ethyl-4,5-dihydroimidazol-2-yl)methyl]-2-methoxybenzamide |
---|---|
Synonym | More Synonyms |
Description | Lintopride is a 5HT4 antagonist with moderate 5HT3 antagonist properties. |
---|---|
Related Catalog | |
Target |
5HT4[1] |
In Vitro | Lintopride significantly increases the lower oesophageal sphincter basal tone without affecting lower oesophageal sphincter physiological relaxation after swallowing. Peristaltic waves are also enhanced by Lintopride[1]. |
References |
Density | 1.35g/cm3 |
---|---|
Boiling Point | 494.1ºC at 760 mmHg |
Molecular Formula | C14H19ClN4O2 |
Molecular Weight | 310.77900 |
Flash Point | 252.6ºC |
Exact Mass | 310.12000 |
PSA | 83.44000 |
LogP | 1.92410 |
Vapour Pressure | 6.62E-10mmHg at 25°C |
Index of Refraction | 1.618 |
Storage condition | 2-8℃ |
UNII-C2R0GEU722 |
Lintopridum [INN-Latin] |
Lintoprida [INN-Spanish] |
Lintopridum |
Lintoprida |
Lintopride |